Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Europe clears Guidant's next-generation HF (heart failure) device:

This article was originally published in Clinica

Executive Summary

Guidant has CE-marked for sale in Europe its next-generation cardiac resynchronisation device for treating heart failure (HF). The CONTAK RENEWAL, which also provides defibrillation therapy, contains new diagnostic capabilities that are designed to help physicians better manage their patients' condition. The product monitors heart rate variability and uses data from an accelerometer sensor to track trends in patients' activity levels.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT071352

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel